SYNDROS is the first FDA-approved cannabinoid used to treat:
SYNDROS is liquid dronabinol containing a cannabinoid indicated for chemotherapy-induced nausea and vomiting (CINV) in people whose nausea and vomiting have not improved with usual anti-nausea medicines.
SYNDROS is liquid dronabinol containing a cannabinoid also indicated for loss of appetite (anorexia) in people with AIDS (Acquired Immune Deficiency Syndrome) who have lost weight.Learn more about SYNDROS for appetite stimulation
Today, you can start saving on your medical expenses by signing up for the SYNDROS Co-Pay Savings Card program. This program can offer you free product and up to $400 off of each new prescription bottle of SYNDROS oral dronabinol solution.
Patients with chronic diseases such as cancer and AIDS may benefit from a liquid formulation of dronabinol tetrahydrocannabinol (THC) therapy. A dronabinol oral solution like SYNDROS may be a fit for you if:
Had an allergic reaction to dronabinol. Signs and symptoms of an allergic reaction to dronabinol include: swelling of the lips, hives, a rash over your whole body, mouth sores, skin burning, flushing and throat tightness.
Had an allergic reaction to alcohol.
Are using a medicine that contains disulfiram (Antabuse) or metronidazole (Pylera, Flagyl, Flagyl ER, Nuvessa, Vandazole) or have taken or received a medicine that contains disulfiram or metronidazole in the last 14 days.
Our patient support program, SYNDROS CaresTM, is designed with patients in mind. This zero dollar, out-of-pocket co-pay arrangement revolves around complimentary, convenient and comprehensive services. Enroll today for individualized outreach and have SYNDROS delivered straight to your door.